102 related articles for article (PubMed ID: 9568174)
1. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract][Full Text] [Related]
2. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
4. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
Weg-Remers S; Hildebrandt U; Feifel G; Moser C; Zeitz M; Stallmach A
Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
9. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer.
Baek JM; Jin Q; Ensor J; Boulbes DR; Esteva FJ
Breast Cancer Res Treat; 2011 Dec; 130(3):1029-36. PubMed ID: 21830016
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of reputed tumor-associated soluble CD44 isoforms (v5 and v6) in smokers are dose related and decline on smoking cessation.
Scott DA; Stapleton JA; Palmer RM; Wilson RF; Sutherland G; Coward PY; Gustavsson G; Odell EW; Poston RN
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1211-4. PubMed ID: 11097229
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients.
Kittl EM; Ruckser R; Selleny S; Samek V; Hofmann J; Huber K; Reiner A; Ogris E; Hinterberger W; Bauer K
Exp Clin Immunogenet; 1997; 14(4):264-72. PubMed ID: 9523162
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum E-cadherin assay in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Ciampi B; Bianchi R; Genazzani AR
Anticancer Res; 1999; 19(1B):769-72. PubMed ID: 10216491
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
Satoh K; Shimosegawa T; Koizumi M; Toyota T
Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
